External cephalic version trial.

Management of breech presentation: external cephalic version with tocolysis: a multicentre randomised controlled trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22775

Enrollment

300

Registered

2005-08-24

Start date

2004-08-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breech presentation.

Interventions

Group 1: external cephalic version with tocolysis (adalat 10 mg orally 30 and 15 minutes before procedure)

Group 2: external cephalic version without tocolysis.

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women (from 18 years of age) with a live singleton at term fetus in breech presentation.

Exclusion criteria

Exclusion criteria: Contraindications to labour or vaginal birth, any contraindication to ECV, contra-indications for nifedipine.

Design outcomes

Primary

Measure	Time frame
Succesfull version.	—

Secondary

Measure	Time frame
1. Cephalic presentation at birth; 2. Caesarean section rate; 3. Fetal complications; 4. Maternal complications.	—

Contacts

Public ContactM. Kok

Academic Medical Center (AMC), Department of Obstetrics and Gynaecology, H4-205, P.O. Box 22660

mkok@amc.uva.nl+31 (0)20 5664167

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)